Arrowhead Pharmaceuticals stock price
애로우헤드 파머슈티컬스NASDAQ:ARWR · Nasdaq · HealthcareToday's signals · No active technical signal.
Signal details →Arrowhead Pharmaceuticals last closed at $64.19 (-0.93%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -28.8×. Its overall grade ranks 407 of 739 stocks in Healthcare.
About this company
Arrowhead Pharmaceuticals last closed at $64.19 (-0.93%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B- · 407/739
Valuation grade B+
Related stocks
- AmgenCustomer
Arrowhead의 RNAi 파이프라인 공동개발·상업화 협력 상대
- GSKCustomer
Arrowhead의 알파-1 항트립신 결핍증 등 공동개발 파트너
- Takeda PharmaceuticalCustomer
Arrowhead의 중증 간질환/희귀질환 프로그램 협력 파트너
ETFs holding this stock
Adaptiv Select ETF · iShares Neuroscience and Healthcare ETF · Alger Mid Cap 40 ETF
Details →About Arrowhead Pharmaceuticals
- What technical signals does Arrowhead Pharmaceuticals (ARWR) have?
- Arrowhead Pharmaceuticals current technical signals: no active technical signal.
- Is Arrowhead Pharmaceuticals a cup-and-handle pattern?
- No. Arrowhead Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Arrowhead Pharmaceuticals?
- Market cap: $8.72B. Trailing 12 months PER: -28.8×. Latest quarter PBR: 19.75×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-04 dataset
Turn what you saw on this name into a strategy
Ask Q about Arrowhead Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.